Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: UK NICE agency not backing Sovaldi


Guru

Status: Offline
Posts: 895
Date:
RE: UK NICE agency not backing Sovaldi
Permalink  
 


Well lets hope the new Abbie drug soon to be approved provides much more realistic pricing. They're never going to make their money back at those prices....Greedy bar stewards might learn something when we are all cured from a much cheaper regime or so I hope!



__________________

Genotype: 3b

VL.�over 15, 000 000

Failed TX 2014: Interferon/Riba.

Cured using Sof/Dak combination.

I can eat cake again! <3 



Guru

Status: Offline
Posts: 5629
Date:
Permalink  
 

Thanks for that Lee, and I posted about it in the HCV News section recently...

http://hepcfriends.activeboard.com/t57845830/nice-uk-consults-on-draft-guidance-on-the-drug-sofosbuvir-so/

The decision hasn`t been finalised yet, it`s still in the consultation stage until 4th July, but it looks likely at the moment that Sovaldi will only be made available to people in the most needy categories over here in the UK.  I`m sure it`s all about budget constraints with our National Health Service already overstretched but I`m keeping my fingers crossed they come to a decision that will benefit as many people as possible.



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 



Guru

Status: Offline
Posts: 1724
Date:
Permalink  
 

It is all about the benjamins.  We need global health care policies where life saving drugs are at stake.  I don't know how anyone can still think what humanity is doing now is working.   

Unless one consider mass suffering and population control through disease "working" but that is just wrong. no



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.



Senior Member

Status: Offline
Posts: 134
Date:
Permalink  
 

 

http://www.reuters.com/article/2014/06/16/us-gilead-sciences-britain-idUSKBN0ER0VI20140616

 

UK cost agency not ready to back Gilead hepatitis C drug

LONDON Mon Jun 16, 2014 5:31am EDT

 
 
 
 
 
 

RELATED TOPICS

 
 
 

(Reuters) - Britain's healthcare cost-effectiveness watchdog NICE said on Monday it needed more information about Gilead Sciences' pricey new hepatitis C drug Sovaldi before deciding if it should be used on the state health service.

The National Institute for Health and Care Excellence (NICE) said it was "minded not to recommend" the drug, which is also known as sofosbuvir. The decision poses a hurdle to its widespread adoption in Britain.

The available evidence shows that sofosbuvir is an effective treatment for chronic hepatitis C in certain patients," said Carole Longson, director of the NICE Centre for Health Technology Evaluation.

"However, evidence is lacking for some subgroups of patients with chronic hepatitis C, and there are also substantial uncertainties in the evidence base presented by the manufacturer."

Sovaldi is far more effective and better-tolerated than older treatments, but its high cost has provoked criticism from healthcare campaigners and insurers.

 

The U.S. price for a 12-week course of treatment with Sovaldi is $84,000, or $1,000 for each once-daily pill. The price in Britain has been set lower at around 35,000 pounds ($58,800). ($1 = 0.5956 British Pounds)



__________________

62 Yrs Old, CHC Geno 3, Cirrhosis, Kidney Transplant (13 yrs), On Sovaldi/Riba Treatment (24 week) since Feb 01,2014

Viral Load 7M on 1/8/2014,  UND at EOT 7/18/2014

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.